Impact of body composition on dose modifications and prognosis in patients with locally advanced gastric cancer - undergoing neoadjuvant chemotherapy

This publication has 22 references indexed in Scilit:

• Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer
  Breast Cancer Research and Treatment, 2021
• The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer
  Breast Cancer Research and Treatment, 2020
• Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy
  Surgery, 2019
• Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
  The Lancet, 2019
• Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
  Breast Cancer Research and Treatment, 2018
• Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis
  Gastric Cancer, 2018
• Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer
  JAMA Oncology, 2018
• ESPEN expert group recommendations for action against cancer-related malnutrition
  Clinical Nutrition, 2017
• Sarcopenia is negatively associated with long‐term outcomes in locally advanced rectal cancer
  Journal of Cachexia, Sarcopenia and Muscle, 2017
• Sarcopenia in gastric cancer: when the loss costs too much
  Gastric Cancer, 2017